---
title: "What Is a 503A Pharmacy? Definition and Rules"
description: "A 503A pharmacy compounds for individual patients on valid prescriptions under 21 U.S.C. 353a. The conditions it meets, and how Cuvo Health routes orders."
canonical: "https://cuvo.co/glossary/503a-pharmacy"
last-updated: "Oct 26, 2026"
---
**Definition:** A 503A compounding pharmacy is a state-licensed pharmacy that compounds drugs for identified individual patients on valid prescriptions under section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a), overseen day to day by its state board of pharmacy.

# What is a 503A compounding pharmacy?

Section 503A is the federal rule for patient-specific compounding by state-licensed pharmacies: a licensed pharmacist prepares a medication for a named patient on a prescription, and the state board of pharmacy oversees the work. Knowing its conditions tells a brand what a compounding pharmacy may and may not fill. Cuvo Health routes every prescription to a licensed partner pharmacy verified for the patient's state, so the brand never vets a compounder itself.

Published Oct 26, 2026. Facts reviewed Oct 26, 2026.

A 503A compounding pharmacy is a state-licensed pharmacy that compounds drugs for an identified individual patient on a valid prescription, under section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a). A preparation that meets the section's conditions is exempt from FDA approval, the federal current good manufacturing practice requirement and the adequate-directions labeling rule, and FDA says state boards of pharmacy hold primary day-to-day oversight of these pharmacies. The route fits telehealth, where a provider writes a prescription for a named patient. On Cuvo Health, each prescription routes to a licensed partner pharmacy verified for the patient's state and operating within the current rules for the molecule, so the brand never contracts or audits a compounder.

**At a glance**
- The law: Section 503A of the FD&C Act, 21 U.S.C. 353a
- Who compounds: A licensed pharmacist in a state-licensed pharmacy or federal facility, or a licensed physician
- The trigger: A valid prescription for an identified individual patient
- Oversight: The state board of pharmacy, with FDA surveillance and for-cause inspections
- Approval status: Compounded drugs are not FDA-approved
- On Cuvo: Orders route to licensed partner pharmacies verified for every ship-to state

**The conditions section 503A sets for a compounded drug**

| Condition | What the statute requires | Citation |
| --- | --- | --- |
| **Patient-specific** | Compounded for an identified patient on a valid prescription; small advance batches only on a history of such prescriptions | 353a(a) |
| **Bulk substances** | A USP or NF monograph, else a component of an FDA-approved drug, else FDA's 503A bulks list; registered maker and certificate of analysis | 353a(b)(1)(A) |
| **Withdrawn drugs** | Not on FDA's list of drugs withdrawn or removed as unsafe or not effective | 353a(b)(1)(C) |
| **Copies** | Not regularly or in inordinate amounts essentially a copy of a commercially available drug | 353a(b)(1)(D) |
| **Difficult drugs** | Not on FDA's list of drugs demonstrably difficult to compound | 353a(b)(3)(A) |

## 01. Why does a 503A pharmacy matter for a telehealth brand?

A compounded medication reaches a patient lawfully only through a pharmacy that meets these conditions, and the brand's name is on the experience either way. The pharmacy's standing decides whether a preparation can be filled, how it is labeled and which board answers a complaint. FDA states that compounded drugs are not FDA-approved and that FDA does not verify their safety, effectiveness or quality before marketing, so a brand's copy should never present a compounded preparation as approved.

On Cuvo, the brand never makes that call. A provider licensed in the patient's state decides whether any treatment is appropriate, and the prescription goes over Surescripts to a licensed partner pharmacy verified for the destination state.

## 02. What can a 503A pharmacy not compound?

It may not regularly compound essentially copies of a commercially available drug. FDA treats a drug on its shortage list as not commercially available, and generally treats it as available again once the shortage is resolved; FDA said on April 1, 2026 that it does not intend to act against a compounder that fills four or fewer prescriptions of such a copy in a calendar month. A prescriber-documented change that makes a significant difference for an identified patient takes a preparation outside the copy limit.

Bulk substances outside the three tests are off limits unless FDA's interim policy places them in Category 1, and FDA says biological products are not eligible for the 503A exemptions at all. This is general information, not legal advice.

## 03. How is a 503A pharmacy different from a 503B facility?

A 503B outsourcing facility registers with FDA, follows current good manufacturing practice, is inspected by FDA on a risk-based schedule and may compound without patient-specific prescriptions. A 503A pharmacy compounds per prescription under its state board. Cuvo's 503A vs 503B guide, linked below, sets out the full comparison and the questions to ask either kind of compounder.

## 04. Who oversees a 503A pharmacy that ships across state lines?

Its home-state board first, and then every state it ships into. California, for example, requires a pharmacy outside the state that ships prescription drugs to Californians to hold a California nonresident pharmacy license and, from July 1, 2026, a California-licensed pharmacist-in-charge (Business and Professions Code section 4112). On Cuvo, each partner pharmacy's licensure for the states it ships into is verified continuously.

## Frequently asked questions

**Q: What is a 503A pharmacy?**

A: A 503A pharmacy is a state-licensed pharmacy that compounds drugs for identified patients on valid prescriptions under section 503A of the FD&C Act, overseen mainly by its state board of pharmacy. On Cuvo, prescriptions route to licensed partner pharmacies verified for every state they ship into.

**Q: 503A vs 503B pharmacy: what is the difference?**

A: A 503A pharmacy compounds per prescription for a named patient under state board oversight, while a 503B outsourcing facility registers with FDA, follows current good manufacturing practice and may compound without patient-specific prescriptions. On Cuvo, each order routes to a partner pharmacy licensed for the destination state and operating within the current rules for the molecule.

**Q: Are drugs from a 503A pharmacy FDA approved?**

A: No. FDA states that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before marketing. On Cuvo, a licensed provider decides whether a compounded or an FDA-approved option fits each patient.

**Q: Who regulates 503A compounding pharmacies?**

A: State boards of pharmacy hold primary day-to-day oversight, and FDA conducts surveillance and for-cause inspections. On Cuvo, each partner pharmacy's licensure for the states it ships into is verified continuously.

**Q: Does a telehealth brand need a 503A pharmacy?**

A: A brand selling compounded medication needs a licensed pharmacy that can fill it lawfully in every ship-to state, but it does not need to own or contract one. Cuvo Health routes prescriptions to licensed partner pharmacies it contracts and verifies, and a brand can bring its own pharmacy at any time.

**Related pages**

- [503A vs 503B compounding](/blog/compounding-503a-vs-503b): The full comparison and the vetting questions
- [503B outsourcing facility](/glossary/503b-outsourcing-facility): The FDA-registered side of compounding
- [Compounded medication](/glossary/compounded-medication): What compounding is, and is not
- [Pharmacy and e-prescribing on Cuvo](/pharmacy): Licensed partner pharmacies, cold chain and lot tracking
- [How to choose a telehealth pharmacy partner](/blog/how-to-choose-a-telehealth-pharmacy-partner): The ten-criterion scorecard
- [Telehealth glossary](/glossary): Every term a telehealth founder meets

Canonical page: https://cuvo.co/glossary/503a-pharmacy